Company Profile
Champions Oncology Stock Price, News & Analysis
- Ticker:
- CSBR
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
4.99 USD (-2.92%)
Close
Last updated: August 11, 2026
79.5M USD
Market cap
Why the stock is moving
As of Aug 11, 2026, CSBR closed down 2.92% at $4.99. No new same-company headline was identified in the current news window.
Company overview
Business overview
Champions Oncology is a precision-oncology company focused on tumor profiling and translational research services. Its business helps pharmaceutical companies and researchers study how cancer behaves.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Champions sits in oncology services and diagnostics.
Business Model Characteristics
The company depends on research demand, service adoption, and the monetization of its tumor-sampling and analytics platform.
Position Within the Biotechnology Landscape
Champions is a diagnostics-and-services name rather than a classic drug-development biotech.
Future catalysts
- Champions Oncology’s catalysts are translational oncology services, data-platform growth, and whether the business can keep scaling its research workflow. The market will watch recurring demand more than binaries.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Champions Oncology (CSBR)?
Champions Oncology (CSBR) most recently closed at 4.99 USD, a -2.92% move versus the previous session.
What is the market cap of Champions Oncology (CSBR)?
Champions Oncology currently has a market capitalization of 79.5M USD on BioPharmSignal.
What does Champions Oncology do?
Champions Oncology is a precision-oncology company focused on tumor profiling and translational research services. Its business helps pharmaceutical companies and researchers study how cancer behaves.
On which exchange is CSBR stock listed?
Champions Oncology (CSBR) is associated with NASDAQ, United States, Biopharma.
What is Champions?
Champions Oncology’s catalysts are translational oncology services, data-platform growth, and whether the business can keep scaling its research workflow.
Which conditions is Champions Oncology targeting with Champions?
Champions Oncology is associated with oncology, cancer therapeutics based on its company overview and current catalyst commentary.
How does Champions Oncology describe recent progress with Champions?
Champions Oncology’s catalysts are translational oncology services, data-platform growth, and whether the business can keep scaling its research workflow.
What is Oncology?
Champions Oncology is a precision-oncology company focused on tumor profiling and translational research services.